Quantum BioPharma Ltd (NASDAQ: QNTM) started the day on Wednesday, with a price decrease of -8.82% at $4.55, before settling in for the price of $4.99 at the close. Taking a more long-term approach, QNTM posted a 52-week range of $3.50-$89.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was 31.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.06%. This publicly-traded company’s shares outstanding now amounts to $1.92 million, simultaneously with a float of $1.58 million. The organization now has a market capitalization sitting at $8.74 million. At the time of writing, stock’s 50-day Moving Average stood at $4.91, while the 200-day Moving Average is $18.96.
Quantum BioPharma Ltd (QNTM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Quantum BioPharma Ltd’s current insider ownership accounts for 17.77%, in contrast to 2.50% institutional ownership.
Quantum BioPharma Ltd (QNTM) Earnings and Revenue Records
Quantum BioPharma Ltd’s EPS increase for this current 12-month fiscal period is 89.06% and is forecasted to reach -1.54 in the upcoming year.
Quantum BioPharma Ltd (NASDAQ: QNTM) Trading Performance Indicators
Let’s observe the current performance indicators for Quantum BioPharma Ltd (QNTM). It’s Quick Ratio in the last reported quarter now stands at 3.76. The Stock has managed to achieve an average true range (ATR) of 0.68.
In the same vein, QNTM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -14.87, a figure that is expected to reach -2.78 in the next quarter, and analysts are predicting that it will be -1.54 at the market close of one year from today.
Technical Analysis of Quantum BioPharma Ltd (QNTM)
If we take a close look at the recent performances of Quantum BioPharma Ltd (NASDAQ: QNTM), its last 5-days Average volume was 0.11 million that shows plunge from its year to date volume of 0.16 million. During the previous 9 days, stock’s Stochastic %D was recorded 15.26% While, its Average True Range was 0.67.
Raw Stochastic average of Quantum BioPharma Ltd (QNTM) in the period of the previous 100 days is set at 5.17%, which indicates a major fall in contrast to 6.77% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 71.72% that was lower than 195.39% volatility it exhibited in the past 100-days period.
